Editors' Highlights in Translational & Clinical Research

This new site provides a snapshot of some of the most exciting research published in Nature Communications from across these fields.
Editors' Highlights in Translational & Clinical Research
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

The Nature Communications editors are featuring a small number of articles recently published in the journal that they believe are particularly interesting or important.

Browse a plethora of diverse studies, ranging from the investigation of the molecular mechanisms underlying the onset and course of a disease using preclinical models, to the development of innovative interventions in human subjects with the goal to guide health care policy and clinical practice.

Visit the site >>
Learn more about the curating editors >>


Image: Getty Images/bingdian

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Tumor Microenvironment Crosstalk and Therapeutic Implications

With this cross-journal Collection, the editors at Nature Immunology, Nature Communications, Communications Medicine and Scientific Reports invite manuscripts that highlight cutting-edge research on TME crosstalk and its therapeutic implications. Topics of interest include immune modulation and checkpoint pathways, cancer-associated fibroblasts and stromal remodeling, angiogenesis and vascular normalization, metabolic reprogramming within the TME, and the role of microbiota in tumor-immune dynamics. We also welcome studies on novel therapeutic approaches that exploit TME vulnerabilities to advance cancer treatment.

Publishing Model: Hybrid

Deadline: Nov 02, 2026